Evidence map›Paper›PMID 21996749›Full record

ArticleOncogene2012

Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8.

D T N Shola, H Wang, R Wahdan-Alaswad, D Danielpour

Abstract read
In one paragraph

Article in Oncogene, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Physiological and pathological roles of Hic‑5 in several organs (Review).International journal of molecular medicine · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. BMP4, a new prognostic factor for glioma.World journal of surgical oncology · 2013
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

D T N SholaCase Comprehensive Cancer Center Research Laboratories, The Division of General Medical Sciences-Oncology, Case Western Reserve University, Cleveland, OH 44106, USA.
H Wang
R Wahdan-Alaswad
D Danielpour
Case Western Reserve University · USUniversity Hospitals of Cleveland · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
RESEARCH ONCOLOGY TRAINING GRANTT32CA059366 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JACKSON, MARK W. · 1993 to 2025
$5.5M
Control of TGF-Beta/Smad Signaling by mTOR in Prostate CancerR01CA134878 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI DANIELPOUR, DAVID · 2009 to 2013
$1.6M
Androgen Control of TGF-beta signalingR01CA102074 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI DANIELPOUR, DAVID · 2004 to 2008
$1.5M
Control of cell growth by mTOR and BMP in prostate cancerF31CA142311 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WAHDAN-ALASWAD, REEMA SAID · 2009 to 2011
$75k
NCI NIH HHS 1F31CA142311NCI NIH HHS 5T32CA059366-15NCI NIH HHS F31 CA142311NCI NIH HHS P30 CA043703NCI NIH HHS P30CA43703NCI NIH HHS R01 CA102074NCI NIH HHS R01CA102074NCI NIH HHS R01 CA134878NCI NIH HHS R01CA134878NCI NIH HHS T32 CA059366
6 · The paper itself

Abstract

Hydrogen peroxide-inducible clone-5 (Hic-5, or androgen receptor-associated protein 55) is a transforming growth factor-β-inducible LIM protein whose deregulation is implicated in the progression of prostate cancer. Here, we report that Hic-5 binds to Smads 1, 5 and 8, and represses bone morphogenetic protein (BMP) signaling responses. Myc-Hic-5 but not Myc-paxillin was specifically immunoprecipitated with anti-FLAG IgG1 from lysates of HEK293 co-transfected with either Myc-Hic-5 or Myc-paxillin and FLAG-tagged Smads 1, 5 or 8. We showed that such interactions require the LIM3 domain of Hic-5 and the MH2 domain of those Smads. Anti-Hic-5 antibody specifically pulled down endogenous Smad1 in both the PC3 human prostate cell line and primary cultures of rat prostate fibroblasts, supporting that Hic-5 binds to Smad1 at the endogenous level. Bacterially expressed glutathione S-transferase (GST)-Smads 1, 5 or 8, but not GST alone, pulled down in vitro transcribed and translated Hic-5, implicating that Hic-5 binds directly to Smads 1, 5 and 8. Significantly, using Hic-5 small hairpin RNA silencing and overexpression systems, we show that Hic-5 (at both the endogenous and exogenous levels) represses the ability of BMP4 to induce expression of the inhibitor of differentiation-1 (Id1; a downstream target gene of BMP), activate the Id1 gene promoter and induce apoptosis in human and rat prostate epithelial cells. Moreover, silencing of Hic-5 in PC3 cells as well as in the WPMY-1 human prostate stroma cell line greatly enhances the levels of endogenous phospho-Smad1/5/8. Finally, we provide fluorescent microscopic imaging to support that Smad1 and Hic-5 mutually interact also at the level of their nuclear export mechanisms. Collectively, these results provide the first evidence for a physical and mutual functional interaction between Hic-5 and the BMP signaling pathway.

Indexed as

AnimalsBone Morphogenetic Protein 4Cell Line, TumorHEK293 CellsHumansInhibitor of Differentiation Protein 1Intracellular Signaling Peptides and ProteinsLIM Domain ProteinsMaleProstatic NeoplasmsRatsSmad1 ProteinSmad5 ProteinSmad8 ProteinBMP4 protein, humanBone Morphogenetic Protein 4ID1 protein, humanInhibitor of Differentiation Protein 1Intracellular Signaling Peptides and ProteinsLIM Domain ProteinsSmad1 ProteinSMAD1 protein, humanSmad5 ProteinSMAD5 protein, humanSmad8 ProteinSMAD9 protein, humanTGFB1I1 protein, human

Identifiers

PMID21996749
PMCPMC3340512
OpenAlexW2007249723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.